Enrolling by invitationNCT07525518
Okami Medical ALPHA Registry
Studying Pulmonary arteriovenous malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Okami Medical, Inc.
- Intervention
- LOBO Vascular Occlusion System(device)
- Enrollment
- 500 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2030
Study locations (1)
- UMASS Chan Medical School, Worcester, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07525518 on ClinicalTrials.govOther trials for Pulmonary arteriovenous malformation
Additional recruiting or active studies for the same condition.